Journals / Journal of Contemporary Medicine / 2016 / Cilt: 6 - Sayı: 1

OVER KİSTİ NEDENİ İLE OPERE EDİLEN HASTALARIN DEĞERLENDİRİLMESİ: RETROSPEKTİF ANALİZ

Pages
11–15
Publication Date
2016-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Özet

Amaç:

🔖

Cite This Article

DOĞRU, H. Y., ÖZSOY, A. Z., ARİCİ, A., GULUCU, S., DEMİRTÜRK, F. (2016). OVER KİSTİ NEDENİ İLE OPERE EDİLEN HASTALARIN DEĞERLENDİRİLMESİ: RETROSPEKTİF ANALİZ. Journal of Contemporary Medicine, Cilt: 6 - Sayı: 1, 11–15. https://ajindex.com/articles/775534

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Hilger WS, Magrina JF, Magtibay PM. Laparoscopic management of the adnexal mass. Clin Obstet Gy- necol 2006;49(3):535–548.
  2. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 1989;74(6):921-6.
  3. Finkler NJ, Benacerraf B, Lavin PT, et al. Comparasion of serum CA 125, Clinical Impression and Ultrasound in the Preoperative Evalution of Ovarian Mass. Obstet Gynecol 1988;72(4):659-64.
  4. Jacobs I, Oram D, Fairbanks J, et al. A risk of malig- nancy index incorporating CA-125, ultrasound and menopausal status or the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol 1990;97(10):922- 929. Tingulstad S, Hagen B, Skjeldestad F, et al. Evaluation of a risk of malignancy index based on serum CA- 125, ultrasound findings and menopausal status in the pre- operative diagnosis of pelvic masses. Br J Obstet Gy- naecol 1996;103(8):826-31.
  5. Tingulstad S, Hagen B, Skjeldestad FE, et al. The risk- of-malignancy index to evaluate potential ovarian can- cers in local hospitals. Obstet Gynecol 1999;93(3):448- 52. Yamamoto Y, Yamada R, Oguri H, et al. Comparison of four malignancy indices in the preoperative evalu- ation of patients with pelvic masses. Eur J Obs Gyn Reprod Biol 2009;144(2):163-7. 8- Kanthikar SN, Dravid NV, Deore PN, et al. Clinico- histopatological analysis of Neoplastic and Non-Ne- oplastic Lesions of the Ovary: A 3-Year Prospective Study Journal of Clinical and Diagnostic Research. 2014;8(8):FC04-FC07. Bast RC, Klug TL, St John E, et al. Aradioimmunas- say using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309(15):883-7.
  6. Chou CY, Chang CH, Yao BL, et al. Color doppler ul- trasonography and serum CA125 the differentiation of benign and malignant ovarian tumors. J Clin Ultra- sound 1994;22(8):491-6.
  7. Niloff JM, Bast RC Jr, Schaetzl EM, Knapp RC. Predic- tive value of CA 125 antigen levels in second-look procedures for ovarian cancer. Am J Obstet Gynecol 1985;151(7):981-6.
  8. Schutter EM, Kenemans P, Sohn C, et al. Diagnos- tic value of pelvic examination, ultrasound,and se- rum CA125 in postmenopausal women with a pelvic mass: an international multicenter study. Cancer 1994;74(4):1398-406.
  9. Medeiros LR, Rosa DD, da Rosa MI, et al. Accuracy of CA-125 in the diagnosis of ovarian tumors: A quantita- tive systematic review. Eur J Obstet Gynecol Reprod Biol 2009;142(2):99-105
  10. Wang J, Sharma A, Ghamande SA et al. Serum protein pro